HPS Pharmacies wish to advise that AbbVie is discontinuing all Chirocaine® (levobupivacaine) products in Australia, as follows:

Product ARTG Approximate discontinuation date
Chriocaine® 50mg/10ml ampoule 76862 December 2022
Chriocaine® 25mg/10ml ampoule 76815 December 2022
Chriocaine® 75mg/10ml ampoule 76864 September 2023
Chriocaine® 250mg/200ml bag 94482 June 2023

No alternative brands of levobupivacaine are currently marketed in Australia.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact AbbVie on 1800 043 460, or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates